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Abstract
Background: The CD8+ T cell immune response fights acute infections by intracellular pathogens and, by
generating an immune memory, enables immune responses against secondary infections. Activation of the CD8+ T
cell immune response involves a succession of molecular events leading to modifications of CD8+ T cell population.
To understand the endogenous and exogenous mechanisms controlling the activation of CD8+ T cells and to
investigate the influence of early molecular events on the long-term cell population behavior, we developed a
multiscale computational model. It integrates three levels of description: a Cellular Potts model describing the
individual behavior of CD8+ T cells, a system of ordinary differential equations describing a decision-making
molecular regulatory network at the intracellular level, and a partial differential equation describing the diffusion of
IL-2 in the extracellular environment.
Results: We first calibrated the model parameters based on in vivo data and showed the model’s ability to
reproduce early dynamics of CD8+ T cells in murine lymph nodes after influenza infection, both at the cell
population and intracellular levels. We then showed the model’s ability to reproduce the proliferative responses of
CD5hi and CD5lo CD8+ T cells to exogenous IL-2 under a weak TCR stimulation. This stressed the role of short-
lasting molecular events and the relevance of explicitly describing both intracellular and cellular scale dynamics.
Our results suggest that the productive contact duration of CD8+ T cell-APC is influenced by the sensitivity of
individual CD8+ T cells to the activation signal and by the IL-2 concentration in the extracellular environment.
Conclusions: The multiscale nature of our model allows the reproduction and explanation of some acquired
characteristics and functions of CD8+ T cells, and of their responses to multiple stimulation conditions, that would
not be accessible in a classical description of cell population dynamics that would not consider intracellular
dynamics.
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Background
Biological systems comprise complex sets of biophysical,
biochemical and cellular processes occurring at multiple
temporal and spatial scales. The strong coupling of those
scales, as well as the circular nature of causality in these
systems [1], calls for the forging of new methods to ex-
plain emerging processes, notably by combining experi-
mental data acquired at those different scales.
The immunological response appears like a promising
test case in this respect because of its inherent complex-
ity, and its large experimentalist community providing
an ever-increasing level of experimental evidences, driv-
ing the modeling process.
Continuous models have been widely used to study
immunological phenomena by simulating how average
densities or concentrations of immune system agents
(e.g., cells [2–5], or molecular species [6]) are changing
over time and by identifying critical parameters that regu-
late the immune response. Although useful in simulating
average responses of the immune system, it is difficult for
continuous models to access the behavior of individual
agents, in response to variations in parameters such as the
duration of T cell and antigen-presenting cells (APC)
interaction [7, 8], T cell cycling time [9] or intercellular in-
teractions [10], that influence T cell responses.
Individual-based models are capable of coupling cell
behaviors (e.g., migration, cell-cell interaction and div-
ision) with spatial concerns (e.g., diffusion of cytokines)
and of yielding information on emerging population dy-
namics. For example, models have been developed to in-
vestigate the motility of T cells and cellular contact
between T cells and APCs [11, 12], T cell strategy to
search for antigens [13] or lymph node output efficiency
[14, 15]. One important advantage of individual-based
modeling approaches is that it allows incorporating
quantitative characterization of the processes at the
single-cell level. However, most of existing models neg-
lect the intracellular mechanisms of cell decisions, hence
limiting their explanatory power.
Baldazzi et al. [16] developed a hybrid model depicting
lymphocyte recruitment and trafficking inside the lymph
node, by coupling a stochastic agent-based description
of cell interactions with a molecular diffusion described
by partial differential equations (PDEs). Nevertheless,
this model does not incorporate intercellular mecha-
nisms controlling cells behavior but rather allows cells
to sense and behave according to the concentration of
specific chemokines in the surroundings. Another hybrid
model was proposed by Santoni et al. [17] for describing
T cell differentiation in the IgE-mediated hypersensitive
reaction. At the intracellular level, this model comprises
a genetic regulatory network (in Boolean formalism) for
translating local cytokine signals (input) into explicit dif-
ferentiation phenotype (output) through the activation
of the represented genes (e.g., markers). At the cellular
scale, the intracellular regulatory network is individually
embedded in each CD4+ T cell using an agent-based
model. The simulation result was able to reproduce cell
population dynamics during a type I hypersensitivity re-
action [17], however it could not generate realistic gene/
protein expression profiles out of the intracellular net-
work [18].
In the last decade, different models and tools [19–28]
have been developed in an attempt to integrate pro-
cesses across multiple scales and data from different re-
sources (e.g., generated from experimental techniques)
in order to explain immune responses. To further our
understanding of the CD8+ T cell immune response, we
have been modeling the CD8+ T cells behavior. We
aimed at uncovering potential mechanisms and the im-
pact of parameters that may help to explain some ex-
perimental observations, such as the responses of CD8+
T cells to different activation conditions. Since cell be-
havior, intracellular signaling and extracellular environ-
ment are inter-connected dynamical processes, an
integration of these dynamics into a single platform re-
quires multiscale modeling. Importantly, this type of
models should produce quantitative simulation results
that can recapitulate as well as explain a biological
phenomenon at multiple scale levels [18].
In the present work, we aim at modeling how, in
response to acute influenza virus infection, antigen-
specific naïve CD8+ T cells become activated in the
secondary lymphoid organs, rapidly proliferate and dif-
ferentiate into effector lymphocytes that mediate viral
clearance [7]. CD8+ T cells express T cell receptor (TCR)
molecules on their surface that can recognize peptides
derived from antigenic proteins bound to the products
of the major histocompatibility complex (MHC) on
APCs (mostly dendritic cells). When encountering cog-
nate antigen-bearing APCs, CD8+ T cells reduce their
rate of motility and eventually form prolonged contacts
with APCs [29, 30], which are accompanied by the en-
gagement of the TCR by peptide-MHC complexes. TCR
engagement induces the synthesis of interleukin-2 (IL-
2), which plays crucial roles in the growth and differenti-
ation of CD8+ T cells [31]. Upon activation through
signals delivered by the TCR and costimulatory molecules,
T cells upregulate IL-2 receptor chains (IL-2R), i.e. IL-2-
Rα (CD25), IL-2Rβ (CD122) and IL-2Rγ (CD132), and
become highly sensitive to IL-2 [27]. Secreted IL-2 binds
IL-2R (IL-2•IL-2R complex) to deliver a key signal for
CD8+ T cell activation [31, 32]. In the presence of strong
antigenic stimulation, CD8+ T cells are able to produce
sufficient IL-2 for activation and proliferation [33].
In a different context, it has been shown that the pro-
liferation of CD8+ T cells with a weak TCR stimulus
requires IL-2 supplement, and T cell sensitivity to IL-2
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strongly affects the extent of proliferation [34]. It is un-
known how IL-2 sensitivity regulates CD8+ T cells be-
havior in the lymph node environment, where activated
CD8+ T cells are influenced by the extra-cellular signals
(e.g., cytokines and chemokines) as well as by interac-
tions with APCs (duration, affinity/amount of antigenic
peptides, co-stimulatory/inhibitory signals…) and other
cell types, justifying the use of multiscale models for ex-
ploring these processes.
Finally, it has been observed that CD8+ T cells detach
from APCs and undergo rapid proliferation after suc-
cessful activation in vivo [35]. Some studies have demon-
strated that the T cell-APC contact duration affects the
quality and magnitude of an immune response [36] and
memory T cell development [37]. Several studies have
identified factors that influence T cell-APC contact dur-
ation including the maturation state of APCs [38], che-
mokines [39] and adhesion molecules (e.g., ICAM-1)
[37]. Clearly, CD8+ T cell activation correlates with T
cell-APC contact duration. However, it is still not clear
how IL-2 influences T cell-APC contact duration.
We previously proposed a multiscale model [40] that
qualitatively reproduces early CD8+ T cell immune re-
sponses in murine lymph nodes. At the intracellular
level, the model comprises a set of ordinary differential
equations (ODEs) describing the dynamics of a molecu-
lar regulatory network driving CD8+ T cell activation
and differentiation. The intracellular processes are em-
bedded in single CD8+ T cells and determine the cell
phenotype through the dynamical functioning of the mo-
lecular regulatory network. At the cellular level, CD8+ T
cells are described within a Cellular Potts model [41, 42].
Cells sense signals via surface receptor-ligand binding, in-
volving either a direct cell-cell contact or diffusive mole-
cules that are secreted by neighboring cells. Here, we use
this model to address “how and how much molecular in-
puts and the microenvironment can affect the behavior at
the population level.” [40].
We first calibrate the model parameters based on in
vivo data. By mimicking acute infections, our model
simulations quantitatively reproduce the CD8+ T cell
population dynamics in murine lymph nodes as well as
the dynamics of some key intracellular signals associated
with CD8+ T cell activation and differentiation. In
addition, using the same parameter values, our model
proves to be able to reproduce another experimental
situation for which it had not been designed: CD8+ T cell
responses to weak antigenic stimulations with different
concentrations of IL-2 supplement. The multiscale nature
of the model allows to understand how different cellular re-
sponses might emerge from subtly different intracellular
profiles, by linking the observation of transient short-term
molecular events to long-term cell population dynamics. Fi-
nally, we show that CD8+ T cells-APC productive contact
duration (i.e. the minimal T cell-APC contact time that al-
lows a naïve T cell to become activated and to proliferate) is
influenced by a balance between exogenous IL-2 availability
and CD8+ T cell intrinsic IL-2 sensitivity, highlighting ex-
perimentally testable model-based predictions.
Results and discussion
Reproducing early CD8+ T cell immune response in
murine lymph nodes
In order to refine the parameter values of our model,
previously obtained in [40], we assessed its ability to re-
produce two types of data generated at two different
scales within 72–120 h post infection (pi) time frame:
1. Molecular data available through the ImmGen
database (Fig. 1a) and
2. Cellular data consisting in the count of F5
transgenic cells in the lymph nodes of mice infected
with Influenza virus (Fig. 1b).
Regarding the molecular behavior of our model, we
observed that the average concentrations of IL-2 and IL-
2R in the simulated cell population increase sharply in
few hours post-infection (IL-2 and IL-2R curves in
Fig. 1a). Around 78 h pi, a high level of IL-2•IL-2R (IL-
2•IL-2R curve in Fig. 1a) appears in the simulations,
which drives some pre-activated CD8+ T cells into the
activation state (Fig. 1c). Following the emergence of
pre-activated cells in the simulations, T-bet expression
increases and peaks around 88 h pi at the population
level (T-bet curve in Fig. 1a). With expansion of effector
cells in the simulated populations, an increase in cellular
contacts (effector-effector and effector-activated cells) el-
evates the frequency of Fas-FasL engagement which
leads to an upregulation of Fas* (simulated Fas* curve in
Fig. 1a), and the consequent cleavage/activation of Cas-
pases (cleaved Caspase curve in Fig. 1a).
Regarding the cellular behavior of our model, the simu-
lated CD8+ T cell population dynamics exhibits a pattern
similar to the in vivo data (Fig. 1b), where cell proliferation
starts at about 90 h pi, and then displays an exponential
growth. Due to asymmetric partition of T-bet between
daughter cells, effector phenotypes appear soon after the
first T cell division (see simulation movie Additional file
1). Around 96 h pi, effector CD8+ T cells dominate the
population in the simulations (Fig. 1c, d). Cell death ap-
pears sporadically following the emergence of effector
cells and becomes frequent at later simulation points (see
simulation movie Additional file 1; 120 h pi in Fig. 1d).
Overall, our model succeeds in reproducing the ex-
pected dynamics of CD8+ T cells in murine lymph
nodes, at both the molecular and cellular scales. Import-
antly, it explains the cellular phenomena by generating
in silico kinetics of the molecular species that match the
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Fig. 1 (See legend on next page.)
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in vivo data (from the ImmGen datasets). In addition,
the model also makes some predictions such as the evo-
lution of the proportion of the different cell types in a
draining lymph node (Fig. 1c) or the evolution of the
cleaved form of Caspase (Fig. 1a), as a function of time.
Parameter sensitivity (see Additional file 2) analyses
indicate a robust performance of this model in reprodu-
cing the in vivo responses of CD8+ T cells to influenza
virus infections. For example, small deviations of the T-
bet or Caspase threshold values (e.g., ±1 pM of the con-
trol value, which corresponds to fits in Fig. 1a) do not
significantly impair the simulation results (Additional file
2: Figure II and III). On the opposite, the IL-2•IL-2R
threshold has a strong influence on the size of the total
cell population and on the intracellular molecular dy-
namics (e.g., the levels of T-bet and cleaved Caspase)
(Additional file 2: Figure I), indicating that the sensitivity
of CD8+ T cells to IL-2 is an important factor regulating
their responses.
Exogenous IL-2 concentration and endogenous IL-2
sensitivity modulate the response of CD8+ T cells to weak
TCR stimulation
The above simulation results illustrate 1) that with
proper parameterization, our model is able to simulate
the early phases of CD8+ T cell immune responses to
strong antigens; 2) how the activation of naïve CD8+ T
cells is induced by autocrine IL-2 production that results
from strong TCR engagement; and 3) the process of ef-
fector cells development. We then wondered to which
extent this model could reproduce other immunological
conditions, for which it was not pre-parameterized. We
decided to assess our model’s ability to reproduce part of
the data reported by Cho et al. [34], which showed that
with weak TCR signals induced by soluble CD3 mono-
clonal antibodies (mAb), IL-2 synthesis by CD8+ T cells
is deficient and the presence of exogenous IL-2 is neces-
sary for their activation and proliferation. In addition,
the reactivity of CD8+ T cells to IL-2 has a good correl-
ation with their CD5 expression, i.e., in vitro prolifera-
tive responses to IL-2 were stronger for CD5hi cells than
CD5lo cells [34]. To further understand these phenom-
ena at different scales as well as to test if our molecular
network could mimic the in vitro IL-2-dependent
proliferation of CD8+ T cells, we performed a set of in
silico experiments (Fig. 2) based on the wet-lab experi-
ments implemented in [34].
To simulate the response of CD8+ T cells to exogen-
ous IL-2 under the antigen-free condition, we removed
APCs from the computational domain and supplied
naïve cells with IL-2 (middle column in Fig. 2). Unsur-
prisingly, at the population level neither cell activation
nor proliferation is observed with or without IL-2 sup-
plement (Fig. 3a; see simulation movies Additional files
3 and 4), which is in good agreement with the in vitro
data [34]. At the intracellular level, no change in mo-
lecular expression is observed in the antigen-free simula-
tions (Additional file 2: Figure IV), which explains the
absence of cellular response.
To test the response of CD8+ T cells to a weak TCR
stimulation, instead of providing the simulated cells with
soluble CD3 mAb as described in [34], we loaded the
APCs in our model with weak antigens aiming to mimic
the low TCR signal strength (right column in Fig. 2). To
this end, we simulated transient cellular contacts be-
tween naïve CD8+ T cells and weak-antigen-loaded
APCs (right column in Fig. 2) based on the finding that
stable T cell-APC interactions are antigen dependent
[39]. This situation mimics in vivo homeostatic prolifera-
tion. We observe that with weak antigenic stimulation,
proliferation of the CD8+ T cells is negligible in the
absence of external IL-2 supplement (Fig. 3a; see simula-
tion movie Additional file 5). Likewise, no cell prolifera-
tion is observed in the simulations supplemented with
less than 0.3 ng/ml IL-2 (Fig. 3b). This is in agreement
with observations that proliferative responses of naïve
CD8+ T cells in the context of weak TCR ligation depend
on IL-2, both in vitro [34] and in vivo. Up to that stage,
our model is then able to reproduce non-straightforward
in vitro biological observations for which it had not been
parameterized.
By contrast, a relative stronger proliferative response
occurs when supplying the simulation domain with
3 ng/ml IL-2 or higher (Fig. 3b; see simulation movie
Additional file 6), as highlighted in vitro by Cho et al.
[34]. By comparing the intracellular dynamics of CD8+ T
cells stimulated by weak antigens with and without IL-2
supplement (Additional file 2: Figure IV), a transient
(See figure on previous page.)
Fig. 1 Reproduction of intracellular and cell dynamics data characterizing an early CD8+ T cell immune response. a Kinetics of IL-2, IL-2R, IL-2•IL-
2R complex, T-bet, Fas* and cleaved Caspase from 72 h pi to 120 h pi. Molecular concentration is represented by squares (in vivo mRNA data,
corresponding to the right-hand y-axis; n = 3; Caspase data are Caspase-3 data from ImmGen) or solid lines (simulation results, corresponding to
the left-hand y-axis; mean value is indicated by a solid line, max and min values are upper and lower boundaries of the shaded areas respectively;
n = 10 simulations). b CD8+ T cell dynamics, from 72 h pi to 120 h pi. Fold change of CD8+ T cell number is represented by cross marks for in vivo
data (mean ± SD; cells were collected from 4 mice at each time point) and by a solid line for simulation results (mean value is indicated by a solid
line, max and min values are upper and lower boundaries of the shaded area respectively; n = 10 simulations). c Proportion of the phenotypes within a
simulated CD8+ T cell population (mean; n = 10 simulations). d Representative in silico simulation snapshots of 72 h, 96 h and 120 h pi. Color-coded
are APCs (green), naïve cells (light blue), pre-activated cells (dark blue), activated cells (orange), effector cells (red) and apoptotic cells (black)
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high level of IL-2•IL-2R complex arising from IL-2
addition is captured at early simulation time points
(Fig. 3c). In fact, this transient peak of IL-2•IL-2R is suf-
ficient to drive some naïve CD8+ T cells into the activa-
tion state (Fig. 3d) and then leads to a subsequent
activation and proliferation of CD8+ T cells, observable
several hours later. Given the fast decay rate of IL-2 in
vivo (average serum half-life is 3.7 min [43]), successful
activation with weak TCR stimulation requires that naïve
CD8+ T cells encounter APCs at early time points so
that they can up-regulate IL-2R before the IL-2
concentration in the surrounding environment becomes
insufficient. Hence, our modeling approach highlights
molecular mechanisms explaining why exogenous IL-2
is the key for the proliferative responses of CD8+ T cells
to a low TCR signal induced by weak antigens in vivo. It
thereby explains the in vitro CD8+ T cell proliferation
induced by a weak TCR stimulation with IL-2 supple-
ment, thus reproducing and explaining biological obser-
vations it had not been designed to describe.
Naïve CD8+ T cells display different IL-2 sensitivities
in vitro; this is correlated with CD5 expression: CD5hi
CD8+ T cells are highly sensitive to IL-2 compared to
CD5lo CD8+ T cells [34]. To further examine the role of
IL-2 signaling in controlling CD8+ T cells response to
weak antigens, we modeled the responses of CD5lo cells
and CD5hi cells by setting the required threshold for IL-
2•IL-2R-induced cell activation at different levels (high
IL-2•IL-2R-threshold (55 pM) for CD5lo cells and low
IL-2•IL-2R-threshold (47 pM) for CD5hi cells) (right-
hand column in Fig. 2). Simulation results show that
cells with a low IL-2•IL-2R-threshold give rise to larger
populations than cells with a high IL-2•IL-2R-threshold
(Fig. 4a). Qualitatively, these simulation results are in ex-
cellent agreement with in vitro simulated homeostatic
proliferations shown in [34] (Fig. 4b).
Even though CD5 levels of CD8+ T cells have been
shown to be correlated with their responsiveness to IL-2
stimulations in weak antigenic contexts (low-level TCR
signals arising from neighboring T cells with self-MHC-I
ligands or weak-antigen-loaded APCs inducing transient
contacts), our simulation results additionally suggest that
the proliferative response of CD8+ T cells to low-level
TCR signals is regulated by a fine tuning of their dynam-
ical response to IL-2 and the IL-2 concentration in the
extracellular environment. From the single cell level, our
simulations indicate a balance between the IL-2•IL-2R
threshold level and the IL-2•IL-2R formation efficiency
determining the activation of individual CD8+ T cells,
which is further detailed in the following section. In
conclusion, our model proved to be able to reproduce
CD8+ T cell responses to multiple activation condi-
tions (e.g., in vivo response to antigens and homeo-
static proliferation) and to make experimentally
Fig. 2 Schematic diagram of in silico experiments designed to test with our model CD8+ T cells productive responses to a weak TCR stimulation
plus IL-2 supplement implemented in [30]
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Fig. 3 CD8+ T cell dynamics in various antigenic stimulation environments in silico. a Only the control population (stimulated with strong
antigens) and the population submitted to a weak antigenic stimulation together with additional IL-2 supplement are able to proliferate (mean ±
SD; n = 10 simulations). b CD8+ T cell dynamics in a weak antigenic condition with graded doses of IL-2 supplement (0.3–10 ng/ml) (mean ± SD;
n = 10 simulations). c IL-2•IL-2R expression (mean; n = 10 simulations) and d the activated cells fold-increases (mean ± SD; n = 10 simulations)
under the conditions of weak antigenic stimulation with or without 10 ng/ml IL-2
a b
Fig. 4 Sensitivity of CD8+ T cells to IL-2 correlates with the strength of proliferation response in the context of weak TCR stimulation. a Simulation
results: proliferative responses of IL-2•IL-2R-threshold-low and -high CD8+ T cells to graded doses of IL-2 supplement (0.3–10 ng/ml) with a weak
antigenic stimulation (Weak Ag) or in antigen-free conditions (No Ag) (mean ± SD; n = 10 simulations). Total CD8+ T cell counts are measured at
120 h pi. b In vitro results (data come from Fig. 5a in [30]): in vitro proliferation of B6 naïve CD5lo and CD5hi CD8+ T cells to a low concentration
of soluble CD3 mAb (0.1 μg/ml) with or without graded concentrations of IL-2 supplement (0.3–10 ng/ml)
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testable predictions (that are further developed in the
following section).
Exogenous IL-2 concentration and endogenous IL-2
sensitivity tune the productive contact duration of CD8+
T cell-APC
Next we measured the impact of different IL-2•IL-2R
threshold levels on the productive T cells-APC contact
duration in response to a strong antigenic stimulation.
We simulated the responses of IL-2•IL-2R-threshold-
high and IL-2•IL-2R-threshold-low CD8+ T cells to
strong antigens, and measured their productive contact
duration with APCs (the minimal contact time between a
naïve T cell and an APC that gives rise to a proliferative T
cell). Simulations show that IL-2•IL-2R-threshold-low
cells have significantly reduced TCR-APC engagement
duration (contact time < 2 h) than IL-2•IL-2R-threshold-
high cells (contact time > 7 h) (Fig. 5a). This result sug-
gests that IL-2 sensitivity of individual naïve CD8+ T cells
may influence their requirement for a prolonged contact
with APCs in vivo. Accordingly, our model predicts
that CD5hi CD8+ T cells may have shorter productive
contact time with APCs comparing to their CD5lo
counterparts in vivo.
In addition to the IL-2 sensitivity, the IL-2•IL-2R for-
mation rate also affects the productive contact duration
of CD8+ T cell-APC, which partially depends on the
amount of IL-2 in the extracellular environment during
TCR engagement. Indeed, we observed that a high con-
centration of exogenous IL-2 (e.g., 10 ng/ml) induced
fast formation of IL-2•IL-2R in CD8+ T cells, which con-
sequently shortened the productive contact time of T
cell-APC (Fig. 5b). Hence, the concentration of exogen-
ous IL-2 could affect CD8+ T cell activation by decreas-
ing the T cell-APC contact time necessary for productive
activation. This result is in accordance with a study by
Filby et al. [44] showing that Fyn−/− CD8+ T cells produ-
cing IL-2 more efficiently require a shorter TCR
engagement duration. Thus this experimental evidence
supports our prediction that T cells require shorter con-
tacts with APCs if they can access abundant IL-2 by
autocrine production or from the neighboring IL-2 pro-
ducing cells (e.g., CD4+ T cells).
Taken together, the productive contact time of T cell-
APC is thus influenced by both the intrinsic IL-2 sensi-
tivity of individual CD8+ T cells and the IL-2 level in the
extracellular environment, a prediction that could be
tested experimentally, at least partially, by modifying the
available IL-2 quantities in the extracellular environment
at different times during the early events of the response
and measuring the subsequent expansion of the popula-
tion. In addition, our model indicates that CD5hi cells
require shorter contact times with APCs to become acti-
vated, which could help them entering a proliferative
state faster than their CD5lo counterparts.
Conclusions
In this paper, we used a multiscale model of CD8+ T cell
dynamics, based on explicit descriptions of cellular dy-
namics with a Cellular Potts model and with cellular
decision-making at the single cell level controlled by a
molecular regulatory network. The main objective was
to address the following questions: how does IL-2 sup-
plement combined with a weak antigenic stimulation in-
duce a visible response? How does heterogeneity within
the naïve CD8+ T-cell pool (e.g., different sensitivity to
the stimulations) may explain variations in the T cell
responses? Answers to those questions are not straight-
forward due to the dynamical, multiscale nature of the
CD8+ T cell behavior. We showed that, by coupling the
different relevant scales, our modeling approach shed
new light on those questions.
After parameter calibration based on in vivo data, this
model was capable of recapitulating the population and
intracellular molecular dynamics of CD8+ T cells in mur-
ine lymph nodes following an influenza virus infection
a b
Fig. 5 The productive CD8+ T cell-APC contact time varies with a the IL-2•IL-2R threshold level of individual T cells (without IL-2 supplement;
mean ± SD; n = 10 simulations) and b the exogenous IL-2 concentration (with IL-2•IL-2R threshold = 51 molars; mean ± SD; n = 10 simulations)
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in a strong antigenic-stimulation context. Overall, the
simulation results are in good agreement with in vivo
experimental data at multiple scales, and showed a ro-
bust performance in reproducing the response of CD8+
T cells to strong antigenic stimulations.
In order to assess the robustness of the model (with
parameter values in Additional file 2: Tables II, III and
IV, calibrated based on the data in Fig. 1), we decided to
assess its ability to simulate other physiological condi-
tions for which it had not been parameterized for, e.g. in
vivo homeostatic proliferation, as modeled in vitro by
Cho et al. [34]. We thus studied the responses of CD8+
T cells to IL-2 supplement in an antigen-free condition
or under a weak antigenic stimulation (weak-antigen-
loaded APCs). No immune response was observed in an
antigen-free condition with or without IL-2 addition.
With a weak TCR signal provided by contacting with
weak-antigen-loaded APCs, addition of large concentra-
tions of exogenous IL-2 was required for CD8+ T cells to
overcome the activation threshold. Compared to CD8+
T cells stimulated with a weak TCR stimulation alone,
exogenous IL-2 led to a transient high level of IL-2•IL-
2R complex at early time points (Fig. 3c) which was
identified as a key force driving some naïve CD8+ T cells
into the activated state (Fig. 3d). A simple examination
of the cellular (Fig. 3a) or molecular (Fig. 3c) levels sep-
arately would not have yielded such kind of insight as
the multiscale integration permitted. It is indeed practic-
ally difficult to predict, without a multiscale model, how
a seemingly tenuous difference (as seen in IL-2•IL-2R
kinetics in the presence or absence of IL-2 at early time
points (Fig. 3c)) can translate into a none-or-all type of
response at the cellular level.
Furthermore, by manipulating the IL-2•IL-2R thresh-
old level of single CD8+ T cells and implementing CD5hi
and CD5lo-like CD8+ T cells, the model allowed a
reproduction of responses involving high affinity (CD5hi)
cells, for which it had been developed, and low affinity
(CD5lo) cells, for which it had not been designed. This
stressed the model robustness to high affinity and low
affinity clones. Second, our simulations of the prolifera-
tive responses of CD5hi and CD5lo CD8+ T cells to a
weak antigenic stimulation in the presence of different
concentrations of IL-2 supplement is in good accordance
with in vitro experimental data [34]. This result suggests
that the difference between CD5hi and CD5lo cells is par-
tially determined by their endogenous sensitivity to IL-2.
It has been shown that stop signals transmitted by
antigen-bearing APCs towards T cells are crucial for T
cell activation, since such signals enhance long-lived in-
teractions between T cells and APCs [12]. However, this
hypothesis has been challenged by naïve T cells becom-
ing activated via brief interactions (<10 min) with
antigen-bearing dendritic cells when placed in a collagen
matrix [45, 46]. In our study, a reduced productive con-
tact time of T cell-APC was observed when lowering the
IL-2•IL-2R threshold for activation, suggesting that the
sensitivity of CD8+ T cells to IL-2 might affect their TCR
engagement requirements. Some studies demonstrate
that the history of T cell-APC interactions experienced
by individual T cells may contribute to the heterogeneity
of T cell responses [47]. Other studies suggest the sensi-
tivity of individual T cells to the activation signals may
predetermine the phenotypes of CD8+ T cells [7, 48].
Taken together, these results indicate that heterogeneity
within the naïve CD8+ T-cell pool (e.g., cells have differ-
ent sensitivity to the stimulations) may partially explain
variations in the T cell responses to antigens, including
T cell-APC contact duration, fate decisions and pheno-
type development.
Although we tried to incorporate as much relevant
biological information as we thought was strictly neces-
sary for reproducing the data we had, there is neverthe-
less ample room for improving our model. For example,
comparing to morphology of dendritic cells in vivo (with
dendrites extended from their center mass), the surface
area of our 2D simulated APCs is small, which limits
their contact frequency with T cells. This limitation is in
part the reason that upper range of our simulation
population size is below the observed data (Fig. 1b).
The use of 2D model instead of a 3D model can also
be seen as a limitation. The computational cost of a 3D
multiscale model is higher than the one of a 2D model,
and mainly justifies our choice to use a 2D model (a 3D
model could however be easily parameterized to repro-
duce experimental data and investigate CD8+ T cell
properties, provided that a large amount of simulations
can be performed in a reasonable amount of time).
Nevertheless, the result on the predicted productive con-
tact duration between T cells and APCs in our model does
not a priori depend on a 2D or a 3D model, since it mainly
relies on the intracellular dynamics and the intracellular
molecular model is deterministic in our current model.
In addition, a refined molecular network incorporating
the Eomesodermin (Eomes) transcription factor could
allow the generation of memory cells, based on some
studies showing that Eomes upregulation together with
T-bet downregulation induces the formation of memory
T cells [49]. Extracellular regulating actors, like CD4+ T
cells that can, among other things, contribute to IL-2
secretion [50], and environmental variables like inflamma-
tion or aging could be considered, leading to refinements
of the model. One of the main limitations here would
be the lack of in vivo lymph node dynamical data that
would be critically needed for proper parameterization
and validation of the added model elements. For example,
a time-dependent characterization in the evolution of the
different cellular subpopulations would permit to assess
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the validity of our predictions (Fig. 1c). Furthermore, it
would be highly valuable to obtain single-cell values of
mRNA expressions for the molecular actors of our net-
work, and their time-dependent evolution during the re-
sponse. The recent advent of single-cell transcriptomics
(see e.g. [51]) could be helpful in that respect.
In conclusion, our multiscale model study indicates
that the CD8+ T cell differentiation process is an ac-
quired property resulting from dynamical interactions
between the intracellular molecular network and envir-
onmental factors. Therefore, it is an ideal platform for
integrating data obtained at different scales and studying
how their coupling explains cellular behaviors of T cells.
Methods
Experimental procedures
Two hundred thousands CD8+ T cells from CD45.1+ F5
TCR transgenic (tg) mice (B6.SJL-PtprcaPepcb/BoyCrl-
Tg(CD2-TcraF5, CD2-TcrbF5)1Kio/Jmar) recognizing the
NP68 epitope were transferred by retro-orbital injection in
6–8 week old congenic CD45.2+ C57BL/6 mice (C57BL6/
J). The day after recipient mice were inoculated intranasally
with 2.105 TCID50 of an H1N1 Influenza virus expressing
the NP68 epitope. From Day 3 to 5.5 post-infection,
the lymph node draining the site of infection (lung,
mediastinal lymph node) was harvested and the number
of F5 transgenic CD8 responder T cells was assessed
by flow cytometry, based on CD8/CD45.1/CD45.2 ex-
pression, to distinguish F5 TCR-tg responder (CD45.1
+CD45.2−) from host (CD45.1−CD45.2+) CD8+ T cells.
mRNA profile
Subcellular mRNA data comes from the ImmGen pro-
ject, http://www.immgen.org. According to the informa-
tion provided on ImmGen.org, the in vivo mRNA data
(presented in Fig. 1a) were generated from spleen OT-1
CD8+ T cells during the course of a response to Listeria-
OVA infection, and normalized using the robust
multi-array algorithm (so normalized values are be-
tween 10 and 20,000). We converted normalized data
into fold change for performing model validation,
based on the expression level in naïve CD8+ T cells
fold change ¼ given dataexpression in naive cell −1
 
.
It must be noted that no in vivo mRNA data is avail-
able for the signaling quaternary IL-2•IL-2R complex,
which is used in this model (see section Modeling
below). In addition, in vivo mRNA data for Fas, which
correspond to the sum of inactivated and activated
forms of Fas, show an almost constant level of expres-
sion throughout the response (data not shown). This in-
formation has been used to describe the dynamics of Fas
and its activated form in the model (we assume a con-
stant level of expression of the total quantity of Fas, and
describe only the dynamics of the activated form, Fas*),
consequently there is no data available for the dynamics
of Fas*.
Modeling
For the reader’s convenience, we present in this section
our multiscale model, previously introduced in [40]. It
consists in the coupling of molecular and cellular dynam-
ics of CD8+ T cells through an explicit description of
single cell dynamics (movements, interactions, cycling)
within the whole population (cellular scale) and a molecu-
lar regulatory network-based decision-making at the single
cell level (subcellular scale). In addition, diffusion of
interleukin-2 (IL-2) in the extracellular environment is ex-
plicitly described and contributes to cell communication.
A detailed description of the model construction and
parameterization can be found in Additional file 2.
Cellular scale: a Cellular Potts model
At cellular scale, we used a Cellular Potts model to de-
scribe cellular behaviors. The implementation of the Cel-
lular Potts model, including the choice of initial
conditions and the characterization of each cell type
(CD8+ T cells and antigen-presenting cells), is detailed in
Additional file 2. We assumed a linear differentiation
pathway for CD8+ T cells (Fig. 6), consisting in naïve T
cells differentiating in pre-activated cells, then in acti-
vated cells, and finally in effector cells, provided cells did
not die while cycling. The state of a dynamical molecular
regulatory network (next section) determines individual
CD8+ T cell’s phenotype and fate, as follows.
In the simulations, naïve CD8+ T cells move constitu-
tively and randomly until encountering APCs (see simu-
lation movie Additional file 1). When a naïve CD8+ T
cell encounters an APC, it becomes pre-activated upon
TCR engagement. During their pre-activated state, T
cells maintain a stable attachment with APCs, and se-
crete IL-2 to the surrounding environment (see simula-
tion movie Additional file 1). The secreted IL-2
combines with IL-2 receptors (IL-2R) to form the signal-
ing quaternary IL-2•IL-2R complex on the cell mem-
branes. Studies indicate that CD8+ T cell proliferation
ensues when reaching a certain activation condition
(e.g., an activation signal exceeding a given threshold)
[7]. Moreover, in vitro studies showed that IL-2 supple-
ment can synergize with weak TCR ligation to induce
the proliferation of naïve CD8+ T cells [34, 52], underlin-
ing the crucial role of IL-2 signaling in CD8+ T cell acti-
vation. Hence, we define an IL-2R occupancy level as
the activation threshold. When the IL-2•IL-2R level
within a pre-activated CD8+ T cell overcomes this
threshold, the T cell becomes activated, detaches from
APC and enters the cell cycle.
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It has been shown that T-bet over-expression pro-
motes the formation of effector phenotype [53]. Hence,
we assume that in our model a cell differentiates into an
effector cell when its T-bet level overcomes a predefined
threshold value (Fig. 6).
We determine CD8+ T cell death by setting a thresh-
old of cleaved Caspase, given the broadly known role of
caspases in immune cell apoptosis [54]. Following differ-
entiation of naïve CD8+ T cells into effector phenotype,
Fas-ligand (FasL) is expressed on cell surface [55]. Fas is
expressed on the activated/effector CD8+ T cell surface
which can bind FasL on the surface of a contacting T
cell [55]. Cellular contacts between Fas-expressing
cells and FasL result in cleaved Caspase activation
and apoptosis [56, 57].
Subcellular scale: a system of ODEs describes the molecular
regulatory network of single CD8+ T cells
Previously, we proposed a simplified molecular regula-
tory network [40] depicting some crucial signaling
(Fig. 7) involved in the early CD8+ T cell immune re-
sponse. The dynamical state of the molecular regulatory
network controls the CD8+ T cell’s phenotype and
fate (see previous section). The description of this
molecular signaling pathway is summarized in Fig. 7
and follows:
Arrow 1: TCR activation induces IL-2R expression
[6, 31].
Arrow 2: TCR activation induces T-bet expression [49].
Arrow 3: IL-2 binds to IL-2R to form the IL-2•IL-2R
complex [6, 31, 32, 58].
Arrow 4: Disassociation of IL-2•IL-2R recycles the
IL-2R to T cell surface [32].
Arrow 5: IL-2•IL-2R enhances the expression of
non-activated IL-2R [32].
Arrow 6: IL-2•IL-2R inhibits IL-2 gene expression
[31, 32, 59, 60].
Arrow 7: IL-2•IL-2R enhances IL-2 gene expression
[31, 32, 59].
Arrow 8: T-bet promotes IL-2 gene suppression via
enhancing the IL-2R inhibition of IL-2 gene [59, 60].
Arrow 9: IL-2 molecule secretion [6, 31, 32, 59].
Arrow 10: IL-2 enhances IL-2•IL-2R formation
[6, 31, 32, 59].
Arrow 11: T-bet inhibits IL-2 secretion [60, 61].
Arrow 12: TCR activation induces IL-2 gene expression
[6, 31, 32].
Arrow 13: TCR activation inhibits Caspase cleavage/
activation [57, 63].
Arrow 14: IL-2•IL-2R inhibits Caspase cleavage/activation
[62].
Arrow 15: T-bet induces FasL expression on effector
cell’s surface [59, 64].
Arrow 16: FasL induces activation of Fas via cell-cell
contact [59].
Arrow 17: Activated Fas (Fas*) induces Caspase
cleavage/activation [57].
Arrow 18: Activation of Fas [59].
Arrow 19: Deactivation of Fas* [57].
Fig. 6 Schematic diagram of the linear in silico activation pathway of CD8+ T cells. A naïve CD8+ T cell becomes pre-activated when it contacts
an APC. The pre-activated T cell evolves to an activated cell when its IL-2•IL-2R complex exceeds a threshold. The activated T cell breaks contact
with APC and enters cell cycle. At the end of an activated T cell’s division, the daughter cells can differentiate into effector phenotype if their
T-bet level exceeds a threshold. Effector T cells keep proliferating leading to the population expansion. The apoptosis of activated and effector T
cells involves the generation of cleaved Caspases (above a threshold), which are induced by Fas-FasL signaling
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Arrow 20: T-bet expression is self-enhanced (i.e., a
positive feedback loop) [65, 66].
One may note that following TCR engagement an
autocrine loop is activated, involving IL-2 and its re-
ceptor IL-2R (arrows 7, 9 and 10). However, this posi-
tive loop is negatively regulated [31, 32, 59, 60] on a
longer time scale (arrow 6) via different signaling
pathways involving Blimp-1 (not explicitly described
in the model) and enhanced by T-bet (arrow 8),
hence controlling IL-2 production throughout the en-
tire response. The dynamics of the regulatory network
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where [R], [L • R], [Tb], [Fs] and [Cas] are the respective
concentrations in IL-2 receptors, activated form of the IL-2
receptors, Tbet, activated Fas, and cleaved caspases. Param-
eters λ denote strengths of feedback controls, parameters k
are decay rates of the corresponding subscripted variables,
μ+ and μ− are association and dissociation rates for IL2-R
and Fas. The term f (APC) in equations (1), (3) and (5) rep-
resents the strength of TCR signaling, assumed here to be
equal to the number of contacting APCs (and equal to zero
when a CD8+ T cell is not contacting an APC). Two add-
itional terms, [IL2cm] and [Tbcm], account for interactions
with the external environment and neighbor CD8+ T cells:
[IL2cm] represents the concentration of IL-2 at the bound-
ary of the CD8+ T cell, in the extracellular environment,
while [Tbcm] represents the sum of all T-bet concentrations
from contacting surrounding CD8+ T cells and implicitly
describes Fas-ligand induced caspase activation. Parameters
values are described in Additional file 2: Table II.
Fig. 7 A simplified molecular regulatory network of a CD8+ T cell
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Extracellular scale: a PDE describes IL-2 production and
diffusion in the extracellular environment
Taking interactive dynamics (arrow 6–9, 11 and 12 in Fig. 7)
into account, we describe IL-2 dynamics in the extracellular
environment (mainly diffusion and degradation) by using a




D∇2½IL2 þ λR3 ½L∙R





The parameter D is the diffusion coefficient of extra-
cellular IL-2, δ its decay rate, and parameters λ represent
strengths of various feedback controls. All parameters
values are described in Additional file 2: Table IV.
Additional files
Additional file 1: CompuCell3D simulation of CD8+ T cells activation
with strong antigenic stimulation. This movie is related to Fig. 1 in the
main text and Additional file 2: Figure IVA. For all the simulation movies,
the color-coded are APCs (green), naïve cells (light blue), pre-activated
cells (dark blue), activated cells (orange), effector cells (red) and apoptotic
cells (black). The diffusion field shows the IL-2 concentration in molars.
(MOV 8752 kb)
Additional file 2: This file contains the model implementation and
parameterization. (DOCX 523 kb)
Additional file 3: CompuCell3D simulation of CD8+ T cells under
antigen-free condition. This movie is related to Fig. 3 in the main text
and Additional file 2: Figure IVB. The color-coded are APCs (green), naïve
cells (light blue), pre-activated cells (dark blue), activated cells (orange),
effector cells (red) and apoptotic cells (black). The diffusion field shows
the IL-2 concentration in molars. (MOV 1368 kb)
Additional file 4: CompuCell3D simulation of CD8+ T cells activation
with 10 ng/ml IL-2 supplement under antigen-free condition. This movie
is related to Fig. 3 in the main text and Additional file 2: Figure IVC. The
color-coded are APCs (green), naïve cells (light blue), pre-activated cells (dark
blue), activated cells (orange), effector cells (red) and apoptotic cells (black).
The diffusion field shows the IL-2 concentration in molars. (MOV 1445 kb)
Additional file 5: CompuCell3D simulation of CD8+ T cells activation
with weak antigenic stimulation. This movie is related to Fig. 3 in the
main text and Additional file 2: Figure IVD. The color-coded are APCs
(green), naïve cells (light blue), pre-activated cells (dark blue), activated
cells (orange), effector cells (red) and apoptotic cells (black). The diffusion
field shows the IL-2 concentration in molars. (MOV 3448 kb)
Additional file 6: CompuCell3D simulation of CD8+ T cells activation
with weak antigenic stimulation plus 10 ng/ml IL-2 supplement. This
movie is related to Fig. 3 in the main text and Additional file 2: Figure
IVE. The color-coded are APCs (green), naïve cells (light blue), pre-
activated cells (dark blue), activated cells (orange), effector cells (red) and
apoptotic cells (black). The diffusion field shows the IL-2 concentration in
molars. (MOV 8335 kb)
Additional file 7: This zip file contains the simulation files used to
generate the results presented in this manuscript. One may note that
CompuCell3D must be installed in order to run the files. (ZIP 122 kb)
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